glp-1 oral liquid drops how to use Compounded GLP-1s: Why doctors worry and the FDA is cracking down Oral GLP-1 Drops – BloomMD
Description
In animal studies, GLP-1RAs consistently reduced drug intake, weakened dopamine release in reward neural networks, and reduced the probability of relapse
Other documented adverse effects include injection site reactions, fatigue, dizziness, and headache
Clinical trials have documented substantial weight loss with these medicationstypically 15% of body weight with semaglutide 2.4 mg (STEP 1 trial) and approximately 21% with tirzepatide 15 mg (SURMOUNT-1 trial) at 72 weeks
However, there have been no recent updates nor published efficacy data regarding this investigational drug
